Tanzania - English - Tanzania Medicinces & Medical Devices Authority

biological e. limited, india - vi polysaccharide bulk conjudate (vi-crm197) - solution for injection - 25

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

biological e. limited, india - vi polysaccharide bulk conjudate (vi-crm197) - solution for injection - 25

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

biological e. limited, india - tetanus toxoid - suspension for injection - ,

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

biological e. limited, india - vitamin - syrup - 10+3+5+150 mg

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

biological e. limited, india - diphtheria , pertusis , tetanus toxoid - suspension for injection - 5

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

biological e. limited, india - hepatitis b virus - suspension for injection - 20 micro grams

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

biological e. limited, india - measles , rubella - vaccine - 10 ccid50/dose

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

biological e. limited, india - measles , rubella - vaccine - 5 ccid50/dose

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

biological e. limited, india - diptheria toxoid,tetanus toxoid,b.pertussis,hepatitis b surface antigen & purified capsular polysaccharide (prp) , - injection - ,

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - mecobalamin, quantity: 5 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - cobalamin deficiency may exist that is unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of vitamin b12 may be insufficient in pernicious anaemia, malabsorption disorders, gastrectomy and gastrointestinal pathologies. specific indications may include: 1. pernicious anaemia as a result of in situ b12 deficiency. in pernicious anaemia co-methylcobalamin is disproportionately reduced in relation to other cobalamins. 2. as an adjunct to the treatment of peripheral neuropathies and diabetic polyneuropathy.